Prostatic Neoplasms: all 6,484 studies

Page 53 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.

• BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)WithdrawnNCT01520441Early Phase 1
• Study of Weekly Cabazitaxel for Advanced Prostate CancerCompletedNCT01518283Phase 2
• Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed TherapyCompletedNCT01516866
• A Pragmatic Trial of the Effect of a Mailed Patient Flyer About Prostate Specific Antigen (PSA) Testing Prior to an Annual ExamCompletedNCT01516801Not applicable
• Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNo longer availableNCT01516762
• Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate CancerActive, not recruitingNCT01514669
• The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate CancerCompletedNCT01513733Phase 1
• Firmagon (Degarelix) Intermittent TherapyTerminatedNCT01512472Phase 4
• Efficacy and Safety Study of ELIGARD 22.5mg With Prostate CancerCompletedNCT01511874Phase 4
• Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate CancerTerminatedNCT01510288Phase 1
• Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the ProstateActive, not recruitingNCT01508390Not applicable
• Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate CancerStatus unknownNCT01505075Phase 1/2
• Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate CancerCompletedNCT01501630
• EMBRACE1: Prostate BiorepositoryCompletedNCT01499381
• Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung CancerCompletedNCT01497925Phase 1
• Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy ParticipantsCompletedNCT01497431Phase 1
• Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic SurgeryCompletedNCT01495130Not applicable
• Effectiveness of Localized Prostate Cancer TreatmentsActive, not recruitingNCT01492751
• Imaging for Significant Prostate Cancer Risk EvaluationStatus unknownNCT01492270Not applicable
• Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate CancerCompletedNCT01491971Phase 2
• The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic CancerStatus unknownNCT01487902Phase 2
• GEMOX in Docetaxel-Refractory Castration-Resistant Prostate CancerCompletedNCT01487720Phase 2
• Hydroxyethyl Starch and Renal Function After Radical ProstatectomyCompletedNCT01486563Phase 4
• The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and StageStatus unknownNCT01484808
• Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer ScreeningCompletedNCT01484665Not applicable
• Safety and Efficacy of Kanglaite Gelcaps in Prostate CancerTerminatedNCT01483586Phase 2
• Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate CancerTerminatedNCT01481441Not applicable
• Oral Colchicine in Men With Castrate Resistant Prostate CancerWithdrawnNCT01481233Phase 2
• A Novel 3D Navigation Technology for Improved TRUS Prostate BiopsyCompletedNCT01480375Not applicable
• Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney CancerActive, not recruitingNCT01480154Phase 1
• An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate CancerStatus unknownNCT01478412
• Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate CancerWithdrawnNCT01478308Phase 2
• Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelTerminatedNCT01469338Phase 2
• MRI for Assessment of Hypoxia-Induced Prostate Cancer AggressivenessActive, not recruitingNCT01464216
• Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies.CompletedNCT01455792Not applicable
• Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking MenCompletedNCT01447186
• Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate BrachytherapyCompletedNCT01446991Phase 2
• Treatment Frequency and Satisfaction in Patients With Advanced Prostate CancerCompletedNCT01441713
• Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy OutcomeActive, not recruitingNCT01441687Not applicable
• Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community SettingCompletedNCT01440855Not applicable
• FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate CancerTerminatedNCT01439542Phase 2
• A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed ImplantStatus unknownNCT01437085
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerActive, not recruitingNCT01436968Phase 3
• Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate CancerStatus unknownNCT01436214Phase 1/2
• Eating, Activity, and Stress EducationCompletedNCT01434004Not applicable
• Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate CancerCompletedNCT01428869
• Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment TimeCompletedNCT01423474Not applicable
• Pilot Study on Focal Prostate Radio-Frequency AblationCompletedNCT01423006Not applicable
• Cabazitaxel With Radiation and Hormone Therapy for Prostate CancerCompletedNCT01420250Phase 1
• PROstate Cancer Imaging, Treatment and Toxicity (PROCITT)CompletedNCT01418040
• DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II StudyCompletedNCT01417676Not applicable
• Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate CancerCompletedNCT01417182Phase 1
• Prostate Cancer Education in African American MenCompletedNCT01415375Phase 2/3
• Tailored Web-Based Intervention for Cancer Patients and Family CaregiversCompletedNCT01415089Not applicable
• Circulating Tumor Cells in Prostate Cancer PatientsTerminatedNCT01414712
• Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerCompletedNCT01414296Phase 1
• Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerCompletedNCT01414283Phase 1
• Spectro-IRM and Evaluation Response to Prostatic RadiotherapyCompletedNCT01412853Not applicable
• Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation TherapyActive, not recruitingNCT01410942Phase 2
• Prostate Cancer Survivors Moving Toward Exercise (PROMOTE) TrialCompletedNCT01410656Not applicable
• HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR BrachytherapyStatus unknownNCT01409876Phase 2
• Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate CancerWithdrawnNCT01409473Phase 2
• Trial of Modifications to Radical ProstatectomyActive, not recruitingNCT01407263Phase 3
• Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer PatientsCompletedNCT01401972
• A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT01400555Phase 1
• Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate CancerStatus unknownNCT01398657Phase 3
• Study of Histrelin Subdermal Implant in Patients With Prostate CancerCompletedNCT01394263Phase 3
• Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScintStatus unknownNCT01394042Early Phase 1
• Safety Study of MGA271 in Refractory CancerCompletedNCT01391143Phase 1
• Pazopanib, Docetaxel, Prednisone ProstateCompletedNCT01385228Phase 1
• A Long-term Observational Study Cohort in Patients With Advanced Prostate CancerCompletedNCT01383863
• Assessment of New Radiation Oncology Technologies and TreatmentsCompletedNCT01379872
• Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate BrachytherapyStatus unknownNCT01379742Phase 4
• Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate CancerCompletedNCT01378091Phase 1
• T-cell-immunity During Standard Radiotherapy in Localised Prostate CancerCompletedNCT01376674
• Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational StudyTerminatedNCT01376661
• Korean Practice Patterns for Screening PCA(Prostate Cancer)CompletedNCT01371513
• Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate CancerCompletedNCT01368055Not applicable
• STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway SignalingWithdrawnNCT01368003Phase 2
• Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical ProstatectomyCompletedNCT01367418Phase 3
• Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH AgonistsCompletedNCT01366053
• Prospective Randomized Trial Comparing Robotic Versus Open Radical ProstatectomyTerminatedNCT01365143Phase 4
• Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate CancerCompletedNCT01359189Phase 1
• Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric ConsequencesStatus unknownNCT01355185
• Active Surveillance Magnetic Resonance Imaging StudyStatus unknownNCT01354171Phase 3
• Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.CompletedNCT01353625Phase 1
• Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) PatientsTerminatedNCT01352208Phase 1/2
• An Open Label Prostate Cancer Study in Japanese PatientsCompletedNCT01351688Phase 1
• Assessing DNA Changes in High Risk Prostate Cancer to Determine PrognosisWithdrawnNCT01350180
• Aggressive Prostate Cancers in Elderly PatientsCompletedNCT01347476
• Preoperative Magnetic Resonance (MR) Imaging of Prostate CancerCompletedNCT01347320Not applicable
• Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by LeuprolideCompletedNCT01344564Not applicable
• Robotic Seed Implantation for Prostate Cancer BrachytherapyTerminatedNCT01341288Phase 1
• Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing SurgeryTerminatedNCT01340599Phase 2
• Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast CancerCompletedNCT01338831Phase 1
• A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate CancerSuspendedNCT01337518Phase 1
• Economic Analyses of the REDUCE TrialCompletedNCT01337258
• Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate CancerCompletedNCT01326286
• The Effects of Epidural Anesthesia on the Bioavailability of Nitric Oxide and Renal Function in Patients Undergoing Laparoscopic SurgeryCompletedNCT01325844Not applicable
• Effectiveness of Open and Robotic ProstatectomyCompletedNCT01325506

← Prostatic Neoplasms overview